10 recruiting, 3 completed, 2 active not recruiting. 14 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 14 | Recruiting 9, Completed 3, Active not recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Anna Stanhewicz, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia Paroxetine Hydrochloride, Ascorbic acid (Vitamin C) - Preeclampsia, Endothelial Function | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 40 | 2026-08-30 | 2026-07-29 |
| MR and Inflammation After Preeclampsia Eplerenone - Preeclampsia, Preeclampsia Postpartum | Early Phase 1 | Active not recruiting | Anna Stanhewicz, PhD | 40 | 2025-12-17 | 2026-01-16 |
| The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy Intradermal Microdialysis, Brain Blood Flow Tests, Local Heating - Gestational Diabetes Mellitus (GDM), Postpartum Women | Phase 1 | Recruiting | Anna Stanhewicz, PhD | 84 | 2025-08-22 | 2025-12-16 |
| Vascular Effects of High-Salt After Preeclampsia Eplerenone - Preeclampsia, Preeclampsia Postpartum | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 40 | 2025-01-02 | 2026-02-13 |
| Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM Insulin aspart - Gestational Diabetes, Endothelial Dysfunction | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 40 | 2024-10-01 | 2026-07-29 |
| Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes Metformin Hydrochloride, placebo - Gestational Diabetes | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 30 | 2024-09-11 | 2025-05-13 |
| Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia Compound 21, Angiotensin II - Preeclampsia | Early Phase 1 | Completed | Anna Stanhewicz, PhD | 24 | 2023-12-08 | 2024-12-24 |
| Sex Differences in the Vascular Effects of E-cigarette Use Local heating + L-NAME (NG-nitro-L-arginine methyl ester; nitric oxide synthase inhibitor), Chronic estrogen exposure - E-cigarette Use | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 80 | 2023-12-02 | 2025-12-15 |
| Daily Aspirin Treatment After Preeclampsia Aspirin, Placebo - Preeclampsia | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 40 | 2023-11-01 | 2025-12-15 |
| Role of NADPH Oxidase in Microvascular Dysfunction Following GDM Acetylcholine, Insulin aspart - Gestational Diabetes, Oxidative Stress | Early Phase 1 | Active not recruiting | Anna Stanhewicz, PhD | 40 | 2023-08-30 | 2026-07-29 |
| Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes Acetylcholine, insulin aspart - Gestational Diabetes, Vascular Endothelial Function | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 28 | 2023-07-01 | 2026-07-29 |
| Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia Compound 21 - Preeclampsia Postpartum | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 30 | 2023-06-28 | 2025-08-24 |
| Prenatal Aspirin and Postpartum Vascular Function Acetylcholine, Endothelin-1 - Preeclampsia, Microvascular Function | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 60 | 2023-01-03 | 2025-05-31 |
| Sex Differences in the Dilatory Response of Compound 21 Compound 21, Compound 21 + losartan - Sex Differences | Early Phase 1 | Completed | Anna Stanhewicz, PhD | 26 | 2022-10-03 | 2024-12-31 |
| Losartan for Improved Vascular Endothelial Function After Preeclampsia Losartan Potassium, Placebo - Preeclampsia Postpartum | Early Phase 1 | Completed | Anna Stanhewicz, PhD | 11 | 2020-11-22 | 2025-07-10 |
Pre-Eclampsia (6) · Diabetes, Gestational (5) · Sedentary Behavior (1) · Vaping (1)
Acetylcholine (3) · Insulin Aspart (3) · compound 21 (3) · Eplerenone (2) · Losartan (2) · Angiotensin II (1) · Ascorbic Acid (1) · Aspirin (1) · Endothelin-1 (1) · Metformin (1) · NG-Nitroarginine Methyl Ester (1) · Paroxetine (1)
United States (15)
R01HL169201 (3), F31HL177925 (1)